Literature DB >> 20716849

Primary aldosteronism with right-dominant heart failure.

Kazuro Sugishita1, Hironori Muraoka, Akiko Kawana, Masako Asakawa, Shin-ichi Usui, Toshiyuki Takahashi.   

Abstract

A 48 year-old obese male with hypertension was admitted to our department because of severe right-dominant heart failure. His heart rhythm was 2:1 atrial flutter and the left ventricle was diffusely hypertrophic and hypokinetic. Primary aldosteronism was diagnosed based on severe hypokalemia (2.6 mEq/L) and a low renin-high aldosterone state with hypertension despite the use of an angiotensin-II receptor blocker, but its etiology could not be clarified with computed tomography, adrenal scintigraphy, and adrenal vein sampling. Ascites and edema rapidly worsened. Ascites aspiration was performed daily, until serum potassium was normalized by a full dose of an aldosterone receptor blocker (spironolactone 100 mg/day). A diuretic (furosemide) was then added. Rate control of atrial flutter was obtained with a beta-adrenergic blocker, and anticoagulation therapy was started. His heart failure was successfully controlled. Coronary arteries were normal on coronary arteriograms, and an endomyocardial biopsy sample obtained from the left ventricle did not show any specific pathological findings. Blood pressure was well controlled with the full dose of the aldosterone receptor blocker, but he died one year later due to intracerebral hemorrhage. As his heart failure was right dominant, we believe that its etiology may have been hyperaldosteronism-induced cardiomyopathy, and not advanced hypertensive heart disease.

Entities:  

Mesh:

Year:  2010        PMID: 20716849     DOI: 10.1536/ihj.51.293

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  1 in total

1.  Biventricular Cardiac Hypertrophy in a Patient with Primary Aldosteronism and Atrial Septal Defect.

Authors:  Tjokorda Gde Dalem Pemayun; Ridho M Naibaho; Muhammad Achmad Sungkar
Journal:  Am J Case Rep       Date:  2017-09-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.